European private equity firm Andera Partners announced that it has co-led the Series A financing round of Adcytherix, a ...

Sino-American oncology specialist BeOne Medicines has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) for sonrotoclax, a potentially best-in ...

German family-owned pharma major Boehringer Ingelheim and AimedBio, a Korean biotech company pioneering antibody-drug ...

Eli Lilly is maintaining its momentum in diabetes and weight loss, presenting impressive data beyond its big-selling dual GLP-1/GIP receptor agonist Mounjaro (tirzepatide).

Japanese drugmaker Taiho Pharmaceutical, a subsidiary of Otsuka, and China-based Haihe Biopharma have entered into an ...

For two decades, US biotech Vertex (Nasdaq: VRTX) built a reputation as one of the few companies to pair cutting-edge science ...

US clinical-stage biotech Spyre Therapeutics on Wednesday announced the closing of its previously announced underwritten public offering of 17,094,594 shares of its common stock, including the full ...

The USA’s 340B hospital markup program is costing taxpayers an estimated $13.4 billion a year in lost Medicare rebates, according to a new report from Berkeley Research Group (BRG).

Los Angeles, USA-based biotech Pelage Pharmaceuticals has announced the close of a $120 million Series B financing.

Chinese biotech Xuanzhu Biopharmaceutical (2575.HK) has raised over HK$780 million ($100 million) through its debut on the ...

California start-up Graph AI has raised $3 million in a seed round led by Bessemer Venture Partners, with the cash to ...